These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 2842130

  • 1. Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study.
    Meier R, Gyr K.
    Eur J Anaesthesiol Suppl; 1988; 2():139-46. PubMed ID: 2842130
    [Abstract] [Full Text] [Related]

  • 2. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis.
    Ozyilkan E, Kahraman H, Onar M, Kesim G, Arik Z.
    East Afr Med J; 1997 Apr; 74(4):210-2. PubMed ID: 9299818
    [Abstract] [Full Text] [Related]

  • 3. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Francavilla R, Barbarini G.
    Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
    [Abstract] [Full Text] [Related]

  • 4. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
    Barbaro G, Di Lorenzo G, Soldini M, Marziali M, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Barbarini G.
    Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
    [Abstract] [Full Text] [Related]

  • 5. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
    Pomier-Layrargues G, Giguère JF, Lavoie J, Perney P, Gagnon S, D'Amour M, Wells J, Butterworth RF.
    Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
    [Abstract] [Full Text] [Related]

  • 6. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
    Van der Rijt CC, Schalm SW, Meulstee J, Stijnen T.
    Gastroenterol Clin Biol; 1995 Jan; 19(6-7):572-80. PubMed ID: 7590022
    [Abstract] [Full Text] [Related]

  • 7. Improvement of hepatic encephalopathy treated with flumazenil.
    Grimm G, Ferenci P, Katzenschlager R, Madl C, Schneeweiss B, Laggner AN, Lenz K, Gangl A.
    Lancet; 1988 Dec 17; 2(8625):1392-4. PubMed ID: 2904525
    [Abstract] [Full Text] [Related]

  • 8. [Current possibilities in the therapy of hepatic encephalopathy].
    Meier PJ, Bansky G.
    Schweiz Med Wochenschr; 1990 Apr 14; 120(15):553-6. PubMed ID: 2159659
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of hepatic encephalopathy with flumazenil].
    Elkjaer JM, Jensen TU, Emborg J.
    Ugeskr Laeger; 2000 Aug 28; 162(35):4681-4. PubMed ID: 10986901
    [Abstract] [Full Text] [Related]

  • 10. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
    Ferenci P, Grimm G.
    Leber Magen Darm; 1989 Dec 28; 19(6):322-5. PubMed ID: 2575692
    [Abstract] [Full Text] [Related]

  • 11. Hepatic Encephalopathy.
    Blei AT, Córdoba J, Practice Parameters Committee of the American College of Gastroenterology.
    Am J Gastroenterol; 2001 Jul 28; 96(7):1968-76. PubMed ID: 11467622
    [Abstract] [Full Text] [Related]

  • 12. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG, Nägele T, Seeger U, Hösl F, Gregor M, Kaiser S.
    Z Gastroenterol; 2005 Apr 28; 43(4):373-8. PubMed ID: 15830303
    [Abstract] [Full Text] [Related]

  • 13. Benzodiazepine antagonist in the treatment of human hepatic encephalopathy.
    Ferenci P, Grimm G.
    Adv Exp Med Biol; 1990 Apr 28; 272():255-65. PubMed ID: 2103692
    [Abstract] [Full Text] [Related]

  • 14. [Effects of lactulose treatment on the course of subclinical hepatic encephalopathy].
    Zeng Z, Li YY.
    Zhonghua Yi Xue Za Zhi; 2003 Jul 10; 83(13):1126-9. PubMed ID: 12921628
    [Abstract] [Full Text] [Related]

  • 15. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
    Cadranel JF, el Younsi M, Pidoux B, Zylberberg P, Benhamou Y, Valla D, Opolon P.
    Eur J Gastroenterol Hepatol; 1995 Apr 10; 7(4):325-9. PubMed ID: 7600138
    [Abstract] [Full Text] [Related]

  • 16. Flumazenil: a benzodiazepine antagonist.
    Hoffman EJ, Warren EW.
    Clin Pharm; 1993 Sep 10; 12(9):641-56; quiz 699-701. PubMed ID: 8306565
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
    Bansky G, Meier PJ, Riederer E, Walser H, Ziegler WH, Schmid M.
    Gastroenterology; 1989 Sep 10; 97(3):744-50. PubMed ID: 2546850
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy.
    Macdonald GA, Frey KA, Agranoff BW, Minoshima S, Koeppe RA, Kuhl DE, Shulkin BL, Lucey MR.
    Hepatology; 1997 Aug 10; 26(2):277-82. PubMed ID: 9252134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.